Fundraising Fox
Hatteras
Venture capitalRaleigh · Late Stage
Find your way into Hatteras
Sign up to see every warm intro you have to Hatteras
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Hatteras team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
What they invest in
from 6 of 7 portfolio companiesBiotech ×4Healthtech ×4AI & Machine Learning ×2Medical Devices ×2Deep Tech ×1Enterprise Software ×1Fintech ×1Retail Tech ×1
HQs:United States×7
Investments · 7 tracked
founders shown can be your intro pathBy year:2025 · 12021 · 12020 · 12016 · 14 dated
Clearside Biomedical is an intellectual property holding, investment, and commercialization company focused on its suprachoroidal space (SCS) ocular drug-delivery platform and microinjector technology.
BiotechHealthtechMedical DevicesAlpharetta, US
Mark Prausnitz(Director)inCharles Deignan(Executive Officer)Glenn Noronha(Executive Officer)inDaniel H. White(Executive Officer, Director)in
BoardEvgeny Zaytsev(Director)Derek Yoon(Director)in
Board seatClay B. Thorp· per SEC Form D · $320K raise · filed Oct 2016
Co-investorsHEALTHCARE ROYALTY PARTNERSMountain Group CapitalSolasta VenturesHatteras Venture Partners
Incyclix Bio develops precision cancer treatments targeting the CDK family of enzymes to restore cell cycle control in tumors, including CDK targets beyond CDK4/6 such as CDK2.
BiotechHealthtechDurham, US
Patrick Roberts(Executive Officer and member of the Board of Managers.)in
BoardFredric N. Eshelman(Executive Officer and member of the Board of Managers.)Sid Subramony(Member of the Board of Managers.)Norman Sharpless(Member of the Board of Managers.)
Co-investorsCape Fear BioCapitalEshelman Ventures, LLCHatteras Venture Partners
Perfuse Therapeutics develops novel ocular therapies for retinal and glaucoma diseases through drug delivery and formulation platforms.
BiotechHealthtechMedical DevicesSan Francisco, US
Sevgi Gurkan(Founder, Chief Executive Officer, and Member of the Board of Directors)in
BoardChristy Shaffer(Director)Chau Khuong(Director)in
Co-investorsOrbiMedAccess BiotechnologyCatalio Capital Management, LPHatteras Venture PartnersLAVLilly Asia Ventures
Santé builds a point-of-sale system designed specifically for liquor retail stores.
AI & Machine LearningEnterprise SoftwareFintechRetail TechSaaSNew York City, US
Darren Fike(Founder)inAntoine Balaresque(CTO)
Co-investorsBonfire VenturesKima VenturesOperator CollectiveTipTop VenturesTrail Run CapitalVeridical Ventures+9 more
Ten63 develops drug-discovery technology that combines generative chemistry with quantum-accurate molecular simulation, including BEYOND (a large quantum chemistry model) and Sentinel (a virtual CSO for target selection), to design therapeutics against previously undruggable targets.
AI & Machine LearningBiotechDeep TechDurham, US
Mark A. Hallen(Executive Officer, Director)inMarcel Frenkel(Executive Officer, Director)Damien Petty(Director)inJia Wei Xu(Director)
Co-investorsCape Fear BioCapitalDFJ DragonFundDraper AssociatesDuke Capital PartnersHatteras Venture PartnersSOSV+4 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Portfolio news
latest coverage across their companiesFrequently asked questions
- How many investments has Hatteras made?
- Hatteras has 7 tracked investments, including 1 dated in the last 24 months.
- What stage does Hatteras invest at?
- Hatteras invests at the Late Stage stage.
- Where is Hatteras located?
- Hatteras is headquartered in Raleigh, US.
Similar investors
83North is a global venture capital firm that invests in and helps entrepreneurs build large, category-defining companies, backing startups across multiple stages and sectors.
Accel is a venture capital firm that partners with exceptional teams, positioning itself as a first partner to founders globally.
Atomico is an international venture capital firm that invests in growth-stage technology companies across multiple geographies. The firm focuses on scaling disruptive technology businesses globally.
August Capital is a venture capital firm that invests in a small number of companies, providing hands-on support to entrepreneurs building their businesses.